FRS2 and breast carcinoma: For example, FGFR amplification in breast cancer affects the phosphorylation of downstream fibroblast growth factor receptor substrate 2 (FRS2), resulting in PI3K/Akt signaling pathway activation.49 High FGFR levels lead to PI3K/Akt pathway activation, which is involved in tumor growth.